Document Detail


Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
MedLine Citation:
PMID:  25395817     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Riociguat (Adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Authors:
Diana Khaybullina; Ami Patel; Tina Zerilli
Related Documents :
10629317 - Endovascular treatment of aortic disease.
11496267 - Identification and implications of transgraft microleaks after endovascular repair of a...
15586527 - Sexual dysfunction in men after open or endovascular repair of abdominal aortic aneurysms.
12757337 - Surgical treatment of post infarction left ventricular aneurysms: our experience with d...
18059107 - Morphometric study of a horseshoe kidney.
24416507 - Unidirectionally progressive left pneumonectomy & mediastinal lymph node dissection.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  P & T : a peer-reviewed journal for formulary management     Volume:  39     ISSN:  1052-1372     ISO Abbreviation:  P T     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-11-14     Completed Date:  2014-11-14     Revised Date:  2014-11-16    
Medline Journal Info:
Nlm Unique ID:  9015516     Medline TA:  P T     Country:  United States    
Other Details:
Languages:  eng     Pagination:  749-58     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmaceutical approval update.
Next Document:  The changing roles of p&t committees: a look back at the last decade and a look forward to 2020.